Šiaurės Lietuvos implantologijos klinika, UAB - financials and debts
Company age: 13 y. 2 mo.
Šiaurės Lietuvos implantologijos klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 101,755 | 112,552 | 125,034 | 166,333 | 252,884 | 240,257 | 249,917 | 218,591 |
| Profit before tax | 5,864 | 17,963 | 36,932 | 35,759 | 61,172 | 24,313 | 53,260 | 42,036 |
| Net profit | 5,470 | 17,042 | 35,084 | 33,995 | 57,942 | 22,994 | 50,309 | 39,154 |
| Equity | 31,760 | 38,367 | 57,451 | 79,881 | 113,802 | 136,796 | 163,575 | 179,200 |
| Liabilities | 11,998 | 8,612 | 12,008 | 19,466 | 111,927 | 125,948 | 78,449 | 56,700 |
| Non-current assets | 25,032 | 27,717 | 21,930 | 15,049 | 130,045 | 119,695 | 105,177 | 90,708 |
| Current assets | 18,370 | 19,145 | 47,344 | 84,298 | 95,560 | 142,941 | 136,667 | 145,123 |
| Total assets | 43,402 | 46,862 | 69,274 | 99,347 | 225,605 | 262,636 | 241,844 | 235,831 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 15,289 | 16,827 | 18,188 |
| Social insurance contributions | - | - | - | - | - | 14,414 | 13,781 | 14,494 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.4% | +10.6% | +11.1% | +33.0% | +52.0% | -5.0% | +4.0% | -12.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.6% | 36.4% | 50.6% | 34.2% | 25.7% | 8.8% | 20.8% | 16.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 17.2% | 44.4% | 61.1% | 42.6% | 50.9% | 16.8% | 30.8% | 21.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.4% | 15.1% | 28.1% | 20.4% | 22.9% | 9.6% | 20.1% | 17.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.8% | 16.0% | 29.5% | 21.5% | 24.2% | 10.1% | 21.3% | 19.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.2 | 0.2 | 0.2 | 1.0 | 0.9 | 0.5 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 18,501 | 22,142 | 25,007 | 33,267 | 50,577 | 45,048 | 49,983 | 39,151 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Šiaurės Lietuvos implantologijos klinika - Social security debts
The company had no debts to Sodra
Šiaurės Lietuvos implantologijos klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-01 | 2026-07-07 | 1.4 |
| 2025-12-05 | 2025-12-05 | 1001.51 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Šiaures Lietuvos implantologijos klinika, UAB (code 303102885) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €218.6K and net profit of €39.2K, with a profit margin of 17.9%. Revenue decreased by 12.5% year on year and was 9.0% lower than two years earlier, showing a decline from the 2024 peak of €249.9K. Profitability also eased from 2024, when net profit reached €50.3K, but remained above the 2023 level of €23.0K. The balance sheet remained stable, with total assets of €235.8K, equity of €179.2K and liabilities of €56.7K at the end of 2025. Equity strengthened over the period while liabilities declined, supporting a strong equity ratio of 76.0% and a debt-to-equity ratio of 0.32. Return on equity stood at 21.9% and return on assets at 16.6%. Asset turnover was 0.93x, and revenue per employee was €43.7K, with profit per employee of €7.8K.